2. Contrast agents
2.1 Context
MRI entered the clinical arena in 1980 and has become a widely democratized diagnostic technique. In fact, over 75 million examinations are carried out worldwide every year. The advantages of MRI are that it is non-invasive, does not use ionizing radiation, has excellent spatial resolution (millimeters for clinical examinations and micrometers for research), and can be applied to any part of the body. However, in some areas, contrast may not be sufficient. This is why compounds have been developed to overcome this problem.
MRI contrast agents first appeared in 1988 in the form of a gadolinium(III)-DTPA (Diethylenetriamine Pentaacetic Acid) complex. Since then, they have taken on considerable importance, with almost 40% of MRI examinations involving...
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference
This article is included in
Healthcare technologies
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Contrast agents
Bibliography
Directory
Organizations
EMA European Medicines Agency http://www.ema.europa.eu
WHO World Health Organization http://www.who.int
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference